Literature DB >> 15955038

Psychiatric comorbidity in the evolution from migraine to medication overuse headache.

F Radat1, C Creac'h, J D Swendsen, M Lafittau, S Irachabal, V Dousset, P Henry.   

Abstract

We set out to study the role of psychiatric comorbidity in the evolution of migraine to medication overuse headache (MOH) by a comparative study of 41 migraineurs (MIG) and 41 patients suffering from MOH deriving from migraine. There was an excess risk of suffering from mood disorders [odds ratio (OR) = 4.5, 95% confidence interval (CI) 1.5, 13.5], anxiety (OR = 5, 95% CI 1.2, 10.7) and disorders associated with the use of psychoactive substances other than analgesics (OR = 7.6, 95% CI 2.2, 26.0) in MOH compared with MIG. Retrospective study of the order of occurrence of disorders showed that in the MOH group, psychiatric disorders occurred significantly more often before the transformation from migraine into MOH than after. There was no crossed-family transmission between MOH and psychiatric disorders, except for substance-related disorders. MOH patients have a greater risk of suffering from anxiety and depression, and these disorders may be a risk factor for the evolution of migraine into MOH. Moreover, MOH patients have a greater risk of suffering from substance-related disorders than MIG sufferers. This could be due to the fact that MOH is part of the spectrum of addictive disorders.

Entities:  

Mesh:

Year:  2005        PMID: 15955038     DOI: 10.1111/j.1468-2982.2005.00910.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  39 in total

Review 1.  Controversy over the classification of medication-overuse headache.

Authors:  Maurice B Vincent
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Medication overuse and chronic migraine.

Authors:  Vincent T Martin
Journal:  Curr Pain Headache Rep       Date:  2009-10

3.  Achieving a balance between the physical and the psychological in headache.

Authors:  Raphael Underwood; Kay Kennis; Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2017-08       Impact factor: 5.386

4.  Sinus venous stenosis-associated idiopathic intracranial hypertension without papilledema as a powerful risk factor for progression and refractoriness of headache.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Vincenzo Bonavita
Journal:  Curr Pain Headache Rep       Date:  2012-06

5.  Treatment of PTSD and Chronic Daily Headache.

Authors:  Todd A Smitherman; Anna Katherine Black; Christal N Davis
Journal:  Curr Treat Options Neurol       Date:  2014-10       Impact factor: 3.598

Review 6.  Medication-overuse headache: epidemiology, diagnosis and treatment.

Authors:  Espen Saxhaug Kristoffersen; Christofer Lundqvist
Journal:  Ther Adv Drug Saf       Date:  2014-04

Review 7.  Medication overuse headache in children and adolescents.

Authors:  Matteo Chiappedi; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2014-04

8.  Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache.

Authors:  Sergio De Filippis; Denise Erbuto; Federica Gentili; Marco Innamorati; David Lester; Roberto Tatarelli; Paolo Martelletti; Maurizio Pompili
Journal:  J Headache Pain       Date:  2008-10-25       Impact factor: 7.277

Review 9.  Pain cognition in migraine: from basic neurophysiology to a behavioral paradigm.

Authors:  Vincenzo Bonavita; Roberto De Simone; Angelo Ranieri
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

10.  Shared genetic factors in migraine and depression: evidence from a genetic isolate.

Authors:  A H Stam; B de Vries; A C J W Janssens; K R J Vanmolkot; Y S Aulchenko; P Henneman; B A Oostra; R R Frants; A M J M van den Maagdenberg; M D Ferrari; C M van Duijn; G M Terwindt
Journal:  Neurology       Date:  2010-01-13       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.